CStone Pharmaceuticals
CSPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $458 | $388 | $679 | $997 |
| Short-Term Investments | $195 | $285 | $179 | $52 |
| Receivables | $100 | $131 | $179 | $172 |
| Inventory | $149 | $286 | $182 | $109 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $901 | $1,090 | $1,218 | $1,330 |
| Property Plant & Equip (Net) | $110 | $131 | $131 | $153 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $156 | $161 | $167 | $173 |
| Long-Term Investments | $5 | -$276 | $13 | $4 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $20 | $288 | $3 | $2 |
| Total NC Assets | $290 | $304 | $314 | $332 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,192 | $1,393 | $1,532 | $1,662 |
| Liabilities | – | – | – | – |
| Payables | $212 | $338 | $245 | $246 |
| Short-Term Debt | $220 | $93 | $98 | $139 |
| Tax Payable | $1 | $2 | $0 | $18 |
| Deferred Revenue | $0 | $0 | -$359 | $0 |
| Other Curr. Liab. | $192 | $249 | $729 | $447 |
| Total Curr. Liab. | $626 | $682 | $713 | $850 |
| LT Debt | $171 | $263 | $236 | $224 |
| Deferred Rev, NC | $80 | $85 | $0 | $62 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $85 | $115 | $69 |
| Total NC Liab. | $251 | $348 | $351 | $355 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $28 | $38 | $28 | $44 |
| Total Liabilities | $877 | $1,030 | $1,064 | $1,205 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$9,381 | -$9,111 | -$9,004 | -$9,020 |
| AOCI | $0 | $470 | $470 | $483 |
| Other Equity | $9,695 | $9,004 | $9,000 | $8,992 |
| Total Equity | $315 | $364 | $468 | $457 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,192 | $1,393 | $1,532 | $1,662 |
| Net Debt | -$66 | -$32 | -$344 | -$633 |